[Tubo-ovarian actinomycosis, intrauterine device and chemotherapy for breast cancer].
Tubo-ovarian actinomycosis was observed after chemotherapy for breast cancer in a patient with an intrauterine device. Does chemotherapy increase the risk? How can it be prevented?